Riskpilot← Back to searchSign inGet full accessMEDUS AS
ASActiveOrg 979728255Nobels Gate 1, 2760 BrandbuWholesale of pharmaceutical and medical goods · NACE 4646Est. 199815 employees
Revenue 2024
NOK 35,7M
-9% vs 2023
EBITDA margin
0.6%
-89% vs 2023
Equity ratio
11.2%
Financial strength
Net profit 2024
NOK -3,4M
-444% vs 2023
| Revenue | NOK 35,7M | -9% |
| EBITDA | NOK 228K | -89% |
| Net profit | NOK -3,4M | -444% |
| Total assets | NOK 28,3M | -17% |
| Equity | NOK 3,2M | -52% |
| Employees | 15 | — |
Legal name
MEDUS AS
Org number
979728255
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24. mars 1998
Share capital
NOK 150 000
Employees
15 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg eller daglig leder alene.
Company purpose
Handel, agentur, samt import/eksport og videresalg av aktuelle produkter, kjøp/salg av datautstyr, samt deltakelse i andre selskap.
Address
Nobels Gate 1, 2760 Brandbu
Phone
+4761329050
Email
medus@medus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13 908 | 17 864 | 18 901 | 15 280 | 10 640 | 12 581 | 16 632 | 18 342 | 16 663 | 16 367 | 15 440 | 18 974 | 23 442 | 34 505 | 39 795 | 39 242 | 35 725 |
| Staff expenses | −2 882 | −3 485 | −3 777 | −4 209 | −3 690 | −3 964 | −4 467 | −5 515 | −5 645 | −5 923 | −5 920 | −6 117 | −6 646 | −8 584 | −10 938 | −11 618 | −10 996 |
| EBITDA | 784 | 632 | 2 379 | 470 | −695 | 721 | 1 472 | 1 766 | 684 | 633 | −1 200 | 547 | 1 225 | 2 937 | 5 390 | 2 154 | 228 |
| Depreciation & amort. | −331 | −623 | −748 | −614 | −176 | −301 | −227 | −75 | −0 | −0 | −2 | −12 | −32 | −74 | −81 | −90 | −83 |
| EBIT | 453 | 9 | 1 632 | −144 | −871 | 420 | 1 244 | 1 691 | 684 | 633 | −1 203 | 534 | 1 192 | 2 863 | 5 309 | 2 064 | 145 |
| Net financials | −244 | 92 | −103 | 65 | 203 | −394 | −220 | −71 | 33 | −486 | −285 | −344 | −598 | −5 | −548 | −591 | −3 531 |
| Profit before tax | 209 | 101 | 1 529 | −79 | −668 | 26 | 1 024 | 1 620 | 717 | 147 | −1 488 | 191 | 594 | 2 858 | 4 761 | 1 473 | −3 386 |
| Tax | 66 | 39 | 456 | 13 | −6 | −0 | 215 | 431 | 190 | 41 | −0 | −0 | −0 | 693 | 1 089 | 488 | −0 |
| Net profit | 143 | 61 | 1 073 | −92 | −662 | 26 | 810 | 1 189 | 527 | 106 | −1 488 | 191 | 594 | 2 165 | 3 672 | 985 | −3 386 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 356 | 8 651 | 8 730 | 6 588 | 8 358 | 9 548 | 10 229 | 10 168 | 10 307 | 10 400 | 11 073 | 15 440 | 18 898 | 23 409 | 25 395 | 33 949 | 28 308 |
| Equity | 1 003 | 1 065 | 1 138 | 1 046 | 384 | 410 | 1 219 | 1 808 | 2 335 | 2 441 | 954 | 1 144 | 1 738 | 3 904 | 7 576 | 6 561 | 3 175 |
| Long-term debt | 2 523 | 2 377 | 0 | 0 | 0 | 2 621 | 2 730 | 1 861 | 1 320 | 1 146 | 896 | 646 | 2 715 | 2 287 | 1 858 | 1 427 | 2 212 |
| Short-term debt | 6 830 | 5 209 | 5 706 | 3 399 | 5 150 | 6 518 | 6 281 | 6 498 | 6 651 | 6 812 | 9 223 | 13 649 | 14 445 | 17 218 | 15 961 | 25 962 | 22 922 |
| Total debt | 9 353 | 7 587 | 7 592 | 5 542 | 7 974 | 9 139 | 9 010 | 8 360 | 7 972 | 7 958 | 10 119 | 14 295 | 17 160 | 19 506 | 17 819 | 27 389 | 25 134 |
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
20082024
Equity ratio
11.2%
This company
38.2%
Market median
-71% vs market
20082024
Return on equity
-106.7%
This company
18.4%
Market median
-680% vs market
20082024
Net profit margin
-9.5%
This company
8.1%
Market median
-217% vs market
20082024
Asset turnover
1.26×
This company
1.12×
Market median
+12% vs market
20082024
Debt / equity
7.92×
This company
0.62×
Market median
-1177% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
WD Deputy Member | Deputy Member | 2010 | — | — |
WD Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
TB Chief Executive Officer | Chief Executive Officer | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lets Eiendom As | Company | 25.0% | 25.0% | 2023 |
Lets Eiendom Ii As | Company | 25.0% | 25.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lets Eiendom As
MEDUS AS Board members of MEDUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wenche Dotset | Deputy Member | 0 companies |
| Wenche Dotset Brunstad | Chief Executive Officer | 0 companies |
| Terje Brunstad | Chief Executive Officer | 0 companies |
| Espen Brunstad | Chairman | 0 companies |
| Hans Brunstad | Board of Directors | 0 companies |